A five-year international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment taken twice daily to suppress herpes simplex virus-2 (HSV-2), which is the most common cause of genital herpes, does not reduce the risk of HIV transmission when taken by people infected with both HIV and HSV-2. The results of the study are published in the New England Journal of Medicine online today, and will appear in the Feb. 4, 2010 issue of the publication.
- Herpes medication does not reduce risk of HIV transmission, UW-led international study findsWed, 20 Jan 2010, 18:01:33 EST
- Herpes medication does not reduce risk of HIV transmissionFri, 8 May 2009, 9:43:36 EDT
- Male circumcision reduces risk of genital herpes and HPV infection, but not syphilisWed, 25 Mar 2009, 17:37:48 EDT
- Control of herpes symptoms does not reduce HIV transmission, international study foundMon, 25 Jan 2010, 12:51:47 EST
- Scientists learn why even treated genital herpes sores boost the risk of HIV infectionSun, 2 Aug 2009, 14:09:46 EDT